Neuropathology and Applied NeurobiologyNeurosciencePeer-reviewed journal article
Collablots: Quantification of collagen VI levels and its structural disorganisation in cell cultures from patients with collagen VI-related dystrophies
Nadia Osegui‐Barcenilla, Maria SendinoiD, Sergio Martín‐González, Itziar González‐MoroiD, Ainhoa Benito‐Agustino, Noemi Torres‐Conde, Andrea López‐MartíneziD, Cecilia Jimenez-MallebreraiD, Arístides López‐MárqueziD, Virginia Arechavala‐GomezaiD
Abstract
AimsThis study aims to develop a quantitative method for assessing collagen VI expression in cell cultures, which is crucial for the diagnosis and treatment of collagen VI-related dystrophies. MethodsWe developed a combined in-cell western (ICW) and on-cell western (OCW) assay, that we have called collablot to quantify collagen VI and its organisation in the extracellular matrix of cell cultures from patients and healthy controls. To optimise it, we optimised cell density and the protocols to induce collagen expression in cultures, as well as the cell fixation and permeabilisation methods. This was completed with a thorough selection of collagen antibodies and a collagen hybridising peptide (CHP). We then used collablots to compare cultures from patients and controls and evaluate therapeutic interventions in the cultures. ResultsCollablots enabled the quantification of collagen VI expression in both control and patient cells, aligning with immunocytochemistry findings and detecting variations in collagen VI expression following treatment of the cultures. Additionally, CHP analysis revealed a marked increase in collagen network disruption in patients compared to the controls. ConclusionsThe collablot assay represents an optimal method for quantifying collagen VI expression and its organisation in culture and assessing the effect of therapies. Key Points- Evaluating therapies for collagen VI-related dystrophies (COL6-RD) requires the quantification of collagen VI levels. - Collablot assays are a novel method for quantifying collagen VI expression and its structural organisation in cell culture. - Due to the significant role of phenotype heterogeneity in this complex disease, quantifying collagen alone might not be adequate for diagnosing COL6-RD, but the addition of a peptide to quantify collagen disorganisation could help in the characterisation of patient cultures.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 7th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nanomechanics of cell-derived matrices as a functional read-out in Collagen VI-related Congenital Muscular Dystrophies
Tom White, Arístides López‐Márquez, … Anna Lagunas·Journal of The Royal Society InterfacePeer-reviewed·Mar 1, 2025
- Collagen type VI regulates TGFβ bioavailability in skeletal muscle
Payam Mohassel, Jachinta E. Rooney, … Carsten G. Bönnemann·bioRxiv·Jun 22, 2023
- The absence of collagen VI reduces systolic function but paradoxically increases Ca2+ release in the rat heart
Anna Maria Krstic, Hussam Moammer, … David J. Crossman·Acta PhysiologicaPeer-reviewed·Dec 22, 2025
- Collagen VI is a conserved pro-fibrotic signal disrupting muscle regeneration across distinct human myopathies
Laura Muraine, Mona Bensalah, … Elisa Négroni·bioRxiv·Oct 17, 2025
- Generation and Characterization of Col6a1 knock-in mice: A Promising Pre-Clinical Model for Collagen VI-Related Dystrophies
Arístides López‐Márquez, Carmen Badosa, … Cecilia Jimenez-Mallebrera·Disease Models & MechanismsPeer-reviewed·Nov 25, 2025
- Type VI collagen is proportionally lower around airways and blood vessels in idiopathic pulmonary fibrosis
Helene Wallem Breisnes, Mehmet Nizamoglu, … Janette Kay Burgess·American Journal of Physiology-Cell PhysiologyPeer-reviewed·Sep 15, 2026